Clinical Trial Update: Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the combination of fluvastatin and ezetimibe to fluvastatin alone for dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Lescol (fluvastatin)
• Zetia (ezetimibe)

Snippet

Sponsor: Novartis | Conditions: Dyslipidemia | Phase 3 | Status: COMPLETED